ASB6 and colorectal adenocarcinoma: UALCAN data analysis revealed that ASB6 was remarkably upregulated in colorectal adenocarcinoma (COAD), and COAD patients with high ASB6 expression exhibited unfavorable OS (Fig. 7A, B).